Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Feb 17, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price (Feb. 15, 2005)
Last Price
(
Feb. 8, 2005)
% Change
Agilent
A
24.39
23.75
2.69
Applied Biosystems
ABI
20.57
20.70
-0.63
BD
BDX
59.39
59.40
-0.02
Beckman
BEC
68.85
69.41
-0.81
Bio-Rad
BIO
57.75
58.28
-0.91
Bruker
BRKR
4.00
4.03
-0.74
GE
GE
36.39
36.43
-0.11
Harvard Bio
HBIO
4.65
4.55
2.20
Invitrogen
IVGN
71.64
73.57
-2.62
Molecular Devices
MDCC
21.32
19.00
12.21
PerkinElmer
PKI
22.88
23.61
-3.09
Sigma
SIAL
62.71
62.65
0.10
Stratagene
STGN
6.74
6.70
0.60
Thermo
TMO
27.38
28.37
-3.49
Waters
WAT
49.91
51.11
-2.35
Index Average
35.90
36.10
-0.55

 

Molecular Devices Shares Climb 12 Percent as Index Falls from Last Week's High

Shares of Molecular Devices climbed 12 percent and Agilent Technologies improved 2.7 percent over the five-day period covered by the BioCommerce Week Index ending Tuesday. Both companies reported their quarterly financials in the last week (see related articles).

Molecular Devices closed at $21.32, up from $19.00 last week, while Agilent closed at $24.39, up from $23.75, leading five companies whose shares rose on the week — Harvard Biosciences, up 2.2 percent, closing at $4.65, Stratagen, up 0.60 percent, closing at $6.70; and Sigma, up 0.10 percent, closing at $62.65.

Thermo Electron and PerkinElmer dropped 3.5 and 3 percent, respectively, as 10 companies saw their share prices fall.

The BCW Index finished down 0.55 percent, closing at $35.90, to end a two-week string of highs since it was established on Sept. 9.

Overall, the index trailed the Dow, which closed the five-day period up nearly 1 percent, while the S&P 500 was up a half percent and the Nasdaq was flat. The Amex pharma index was up nearly 1 percent while biotech index was down a fraction.

 

Following is a schedule of quarterly financial reporting dates for the BCW Index companies:

  • Bio-Rad: Feb. 17
  • Bruker BioScience: No date set
  • Harvard Bioscience: March 4
  • Invitrogen: Feb. 17
  • Stratagene: No date set

 

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.